Oncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore joint scientific consultations; what they mean and why they are important to manufacturer...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read moreWe summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...
Read moreFimea program aims to standardise the initiation of assessment which are currently different for out...
Read moreThe Project Orbis initiative is an international partnership between medicines regulators in the UK,...
Read moreCollectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read more